171 related articles for article (PubMed ID: 20544685)
1. HIF-1alpha is a prognostic marker in oral squamous cell carcinomas.
Eckert AW; Schutze A; Lautner MH; Taubert H; Schubert J; Bilkenroth U
Int J Biol Markers; 2010; 25(2):87-92. PubMed ID: 20544685
[TBL] [Abstract][Full Text] [Related]
2. HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor.
Fillies T; Werkmeister R; van Diest PJ; Brandt B; Joos U; Buerger H
BMC Cancer; 2005 Jul; 5():84. PubMed ID: 16035955
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
[TBL] [Abstract][Full Text] [Related]
5. HIF-1alpha expression profile in intratumoral and peritumoral inflammatory cells as a prognostic marker for squamous cell carcinoma of the oral cavity.
Mendes SO; dos Santos M; Peterle GT; Maia Lde L; Stur E; Agostini LP; de Carvalho MB; Tajara EH; Louro ID; Trivilin LO; da Silva-Conforti AM
PLoS One; 2014; 9(1):e84923. PubMed ID: 24416312
[TBL] [Abstract][Full Text] [Related]
6. Associations among pretreatment tumor necrosis and the expression of HIF-1α and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof.
Chen TC; Wu CT; Wang CP; Hsu WL; Yang TL; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2015 Nov; 51(11):1004-1010. PubMed ID: 26365985
[TBL] [Abstract][Full Text] [Related]
7. Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis.
Zhou J; Huang S; Wang L; Yuan X; Dong Q; Zhang D; Wang X
World J Surg Oncol; 2017 May; 15(1):104. PubMed ID: 28521842
[TBL] [Abstract][Full Text] [Related]
8. The correlation between HIF-1 alpha and VEGF in oral squamous cell carcinomas: Expression patterns and quantitative immunohistochemical analysis.
Lee LT; Wong YK; Chan MY; Chang KW; Chen SC; Chang CT; Wang J
J Chin Med Assoc; 2018 Apr; 81(4):370-375. PubMed ID: 29289482
[TBL] [Abstract][Full Text] [Related]
9. [Expression of hypoxia-inducible factor 1α is associated with lymph node metastasis in oral squamous cell carcinoma].
Li JN; Feng ZE; Wang L; Wang YX; Guo CB
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):26-32. PubMed ID: 29483718
[TBL] [Abstract][Full Text] [Related]
10. Significance of HIF-1α Expression and LOXL-2 Localization in Progression of Oral Squamous Cell Carcinoma.
Bharti A; Urs AB; Kumar P
Asian Pac J Cancer Prev; 2021 Feb; 22(2):341-347. PubMed ID: 33639646
[TBL] [Abstract][Full Text] [Related]
11. Siah-1 is associated with expression of hypoxia-inducible factor-1α in oral squamous cell carcinoma.
Aga M; Kondo S; Wakisaka N; Moriyama-Kita M; Endo K; Nakanishi Y; Murono S; Sugimoto H; Ueno T; Yoshizaki T
Auris Nasus Larynx; 2017 Apr; 44(2):213-219. PubMed ID: 27616748
[TBL] [Abstract][Full Text] [Related]
12. Does Hypoxia-Inducible Factor -1 α (HIF-1α) C1772T polymorphism predict short-term prognosis in patients with oral squamous cell carcinoma (OSCC)?
Prasad J; Goswami B; Gowda SH; Gupta N; Kumar S; Agarwal K; Mehra P; Pahuja BK; Chauhan A
J Oral Pathol Med; 2018 Aug; 47(7):660-664. PubMed ID: 29675970
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
[TBL] [Abstract][Full Text] [Related]
14. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers in stage I oral cavity squamous cell carcinoma.
Dunkel J; Vaittinen S; Grénman R; Kinnunen I; Irjala H
Laryngoscope; 2013 Oct; 123(10):2435-41. PubMed ID: 23918741
[TBL] [Abstract][Full Text] [Related]
16. Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma.
Shieh TM; Chang KW; Tu HF; Shih YH; Ko SY; Chen YC; Liu CJ
Oral Oncol; 2010 Sep; 46(9):e47-53. PubMed ID: 20656543
[TBL] [Abstract][Full Text] [Related]
17. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.
Piao S; Liu Y; Hu J; Guo F; Ma J; Sun Y; Zhang B
PLoS One; 2012; 7(8):e42540. PubMed ID: 22880026
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia inducible factor: a potential prognostic biomarker in oral squamous cell carcinoma.
Qian J; Wenguang X; Zhiyong W; Yuntao Z; Wei H
Tumour Biol; 2016 Aug; 37(8):10815-20. PubMed ID: 26880584
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of hypoxia inducible factor 1α in esophageal squamous cell carcinoma.
Munipalle PC; Viswanath YK; Davis PA; Scoones D
Dis Esophagus; 2011 Apr; 24(3):177-81. PubMed ID: 21073615
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway.
Naruse T; Kawasaki G; Yanamoto S; Mizuno A; Umeda M
Anticancer Res; 2011 Dec; 31(12):4429-37. PubMed ID: 22199311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
